Therapeutics, Inc. (Nasdaq: ALTH) announced the presentation of positive new findings from its Phase 3 clinical trial of the investigational ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE